Skip to main content

Diabetes Mellitus: Non-Pharmacological Therapy!

 

NON PHARMACOLOGICAL THERAPY 

  1. MNT
  2. Glycemic Index
  3. Dietary supplements
  4. Weight measurements
  5. Physical Activity
  6. Psychological assessment
  7. Immunizations

2.GLYCEMIC INDEX

"The Glycemic index of a carbohydrate containing food is determined by comparing the glucose excursions after consuming 30g of test food with glucose excursions after consuming 50g of reference food (white bread)"

Glycemic Index= Blood glucose area under the curve (3hr) for test food / Blood glucose area under the curve (3hr) for reference food

  • Low glycemic index foods have value of 53 or less and include many fruits, vegetables, grainy breads, legumes, etc.

  • High glycemic index foods have value of 70 or greater and include baked potatoes, white bread, etc.

3.DIETARY SUPPLEMENTS

  • Patients may seek and use dietary supplements in the treatment of diabetes. 
  • Remember, despite the popular notion, there is no "diabetes specific diet".
  • Data from randomized controlled trials seem to support the efficacy of Coccina indica and American ginseng for improving glucose control.
  • Other studies include supplements such as Chromium, Gymnema sylvester, Aloe vera, Vanadium, Momordica charantia, Nopal, etc.


4.WEIGHT MEASUREMENTS

  • Moderate weight loss in patients with T2DM have shown to decrease cardiovascular diseases as well as preventing or delaying the onset of DM in those at high risk.
  • The recommended primary approach to reduce the weight is Therapeutic lifestyle change (TLC) which indicates a 7% reduction in body weight and an increase in physical activity. A slow but progressive weight loss of 0.45 to 0.9 kg per week is preferred.
  • A general rule for weight loss diet is that they should supply at least 1000 to 1200 kcal/day for women and 1200 to 1600 kcal/day for men.
  • Gastric reduction surgeries when used as a part of comprehensive approach to weight loss are recommended for considerations in patients with T2DM and a BMI that exceeds /m2.

5.PHYSICAL ACTIVITY

  • Recommended physical activity goals for patients with T2 DM include 150 minutes per week of moderate to vigorous aerobic exercise spread out during at least 3 days of the week.
  • Walking, Swimming, cycling Gardening and usual house-cleaning tasks are good exercises that could be encouraged.

6.PSYCHOLOGICAL ASSESSMENT

  • Clinicians should incorporate psychological assessment and treatment in routine care.
  • The ADA guidelines recommend ongoing psychological screening.
  • Patients demonstrating poor self-management should be screened for diabetes related distress, depression, anxiety, eating disorder and cognitive impairment.

7.IMMUNIZATIONS

  • Early Influenza vaccinations commonly called flu shots, are recommended for all patients with DM of 6 months of age or older.
  • Pneumococcal vaccinations are recommended for patients with DM who are 2years of age or older as a one-time vaccination. 
  • Revaccination is also indicated in patients with Nephrotic syndrome or chronic renal diseases and transplantation.
  • Hepatitis B vaccine series should be administered in patients according to the recommendations of Center of Disease Control and Prevention.

Labels

Labels:

Comments

Post a Comment

Popular posts from this blog

Diabetes Mellitus: Pharmacotherapy- Gliptins and a-Glycoside Inhibitors!

  PHARMACOTHERAPY:  Medications classifications include:  Sulfonyl Urea's Nonsylfonylurea Secretagogues (a-Glinides) Biguanides Thiazolidinediones a-Glucosidase Inhibitors Dipeptidyl Peptidase-4 Inhibitors (Gliptins) Sodium-glucose co-transporter (SGLT) Inhibitors  Central-Acting Dopamine Agonists Bile Acid Sequestrants Insulin therapy 5. a-GLUCOSIDASE INHIBITORS Acarbose and Miglitol are a-glucosidase inhibitors currently approved in the United States. Mechanism of Action: An enzyme that is along the brush border of the intestine cells called a-glucosidase; breaks down the complex carbohydrates into simple sugars, resulting in absorption. The a-glucosidase inhibitors work by delaying the absorption of carbohydrates from the intestinal tract, which reduces the rise in postprandial glucose levels. Therapy: As a monotherapy , a-glucosidase inhibitors primarily reduce post-prandial glucose excursions.  Clinical Use: FPG concentrations have been decreased by 40-5...
Post a Comment
Read more

Diabetes Mellitus: Types!

TYPES OF DIABETES MELLITUS 1. TYPE1 DM Type 1 DM is usually diagnosed before age 30 years, but it can develop at any age. T1DM is an autoimmune disease in which insulin producing B-cells are destroyed. The presence of Human Leucocyte Antigens (HLAs ) is associated with the development of T1DM. In addition, these individuals often develop Islet cell antibodies , Insulin Autoantibodies or Glutamic Acid decarboxylase autoantibodies . At the time of development of diagnosis of T1DM, it is usually believed that most of the patients have 80-90%loss of beta cells. The remaining beta cells function at the diagnosis creates a " HONEYMOON PERIOD" during which the blood glucose levels are easier to control, and smaller amounts of insulin are required. after this, the remaining beta cells function is completely lost, and the patients become completely deficient of insulin and hence require exogenous insulin.  2. TYPE1.5 DM:  Also referred as Latent autoimmune diabetes in Adults (LAD) ...
Post a Comment
Read more

Diabetes Mellitus: Etiology and Epidemiology!

 DIABETES MELLITIS Definition: Diabetes Mellitus (DM) describes a group pf chronic metabolic  disorders characterized by hyperglycemia that may result in long-term microvascular, macrovascular and neuropathic complications. these complications contribute to diabetes being the leading cause of: a) new cases of blindness among adults b) end stage renal diseases c)non-traumatic lower limb amputations Etiology: The increasing prevalence is caused by three influences: 1. ethnicity        2. Lifestyle       3. Age Types: a) Type 1 DM b) Type 2 DM c) Type 1.5DM d) Gestational Diabetes Mellitus (GDM) ** In type 1 DM; the body fails to make insulin. In type 2 DM; body either develops resistance to insulin or not enough insulin is produced to lower the Blood glucose levels** Epidemiology The worldwide prevalence of DM has risen over past two decades with an estimation of 30 million cases in 1985 to 177 million cases in 2000. Based on current trend...
Post a Comment
Read more